Saccadous

Scottsdale, Arizona, United States

Saccadous, Inc. is a digital health startup dedicated to providing a non-invasive platform (hardware, software and analytics) for diagnosing, tracking and advancing the treatment of neurological disorders such as Parkinson's disease and related movement disorders. This is done through the capture and analysis of involuntary eye-movements, called microsaccades.During visual fixation, the eyes are never completely still, but produce small involuntary movements, called “fixational eye movements,” including microsaccades, drift, and tremor. The research and intellectual property (IP) we have licensed has proven that the many microsaccade attributes, when compared, show patterns that can be used to identify and differentiate subjects.Saccadous, Inc. was founded and awarded initial funding in January 2014, through the ASU “Furnace” Technology Transfer Accelerator. Furnace is an innovative startup accelerator designed to form, incubate and launch new companies. Saccadous selected, competed and won the Furnace competition using eye movement technology and IP from Dignity Health.The Saccadous solution is mobile & non-invasive, engineered to function on a mobile device and architected to leverage a global API accessible cloud-based infrastructure. The intelligence (algorithms) sits in the cloud and provides near real-time analytics and modeling. Big Data can and will make health care better.This research adds involuntary eye movements as a new evidence-based data source. Medicine has entered its digital age, mobile technologies, sensors, and advances in analytics make it possible to capture and decipher vast amounts of information. The sum of this information will transform healthcare and clinical research, transforming a field aimed at treating the average patient into one that’s much more customized.Follow us on Twitter -- @saccadous

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Saccadous on @MedStartr Today #NeurologicalDisorders #Diagnostics #BigData #MedMo #MedStartrVentures

https://www.medstartr.ai/s/irUsLpucFb4

Get Involved in Saccadous

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2014
Website: www.saccadous.com/

Disease Areas

Neurological Disorders Diagnostics

Technologies

Big DataAnalyticsSensorsMobile Technology

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Saccadous?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.